Serum Antiphospholipid Antibodies in Transplanted Patients: Potential Follow-up Markers to Assess Pregnancy Risk?

Transplantation. 2015 Sep;99(9):e152-4. doi: 10.1097/TP.0000000000000835.

Authors

Elena Ortona¹, Tania Colasanti, Martina Derme, Isabella Iannini, Marta Vomero, Maurizio Sorice, Francesca D'Alessandro, Alessandro Nanni Costa, Walter Malorni, Giuseppe Orlando, Marialuisa Framarino-dei-Malatesta

Affiliation

¹ 1 Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, Rome, Italy. 2 San Raffaele Pisana Institute, Rome, Italy. 3 Department of Gynecological, Obstetrical and Urological Sciences, I School of Medicine, "Sapienza" University of Rome, Rome, Italy. 4 Department of Experimental Medicine, "Sapienza" University of Rome, Rome, Italy. 5 Italian National Transplant Centre, Rome, Italy. 6 Department of Therapeutic Research and Medicine Evaluation, Istituto Superiore di Sanità, Rome, Italy. 7 Wake Forest School of Medicine, Winston Salem NC.

PMID: 26308418
DOI: 10.1097/TP.0000000000000835

No abstract available

Publication types

Letter

MeSH terms

Adult
Antibodies, Antiphospholipid / blood*
Antiphospholipid Syndrome / blood
Antiphospholipid Syndrome / diagnosis
Antiphospholipid Syndrome / immunology*
Biomarkers / blood
Case-Control Studies
Enzyme-Linked Immunosorbent Assay
Female
Gestational Age
Humans
Organ Transplantation / adverse effects*
Pilot Projects
Predictive Value of Tests
Pregnancy
Pregnancy Complications / blood
Pregnancy Complications / diagnosis
Pregnancy Complications / immunology*
Pregnancy Outcome
Risk Assessment
Risk Factors
Time Factors
Young Adult

Substances

Antibodies, Antiphospholipid
Biomarkers